Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A4 | P26447 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | BCL2 | P10415 | 3/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | PTPRC | P08575 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30494516 | 0.95 | S100A4 (0.41) | S100A4CYP1A2BCL2MCL1CA1 | |
| SCHEMBL22233097 | 0.88 | PTPRC (0.50) | S100A4CYP1A2BCL2MCL1PTPRC | |
| SCHEMBL28680807 | 0.81 | S100A4 (0.43) | S100A4CYP1A2BCL2MCL1PTPRC | |
| SCHEMBL734024 | 0.76 | ALOX15 (0.39) | — | |
| SCHEMBL735361 | 0.74 | ELANE (0.36) | — | |
| SCHEMBL16193369 | 0.73 | — | — | |
| SCHEMBL733492 | 0.71 | APEX1 (0.33) | CA1CA2CA9 | |
| SCHEMBL9354025 | 0.70 | CA1 (0.40) | S100A4CYP1A2BCL2MCL1CA1 | |
| SCHEMBL23968936 | 0.70 | BCL2 (0.54) | S100A4CYP1A2BCL2MCL1ESR1 | |
| SCHEMBL16682965 | 0.70 | BCHE (0.53) | S100A4CYP1A2BCL2MCL1PTPRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11322694-B2 | Electroluminescent material, method for manufacturing same, and light emitting device | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2022-05-03 | — | — | US | disclosed |
| US-20210336152-A1 | ELECTROLUMINESCENT MATERIAL, METHOD FOR MANUFACTURING SAME, AND LIGHT EMITTING DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11322694-B2 | Electroluminescent material, method for manufacturing same, and light emitting device | GPR17, CALCR, TAAR1 | S100A4 2471/4885CYP1A2 2184/4885BCL2 3739/4885 |
| US-20210336152-A1 | ELECTROLUMINESCENT MATERIAL, METHOD FOR MANUFACTURING SAME, AND LIGHT EMITTING DEVICE | GPR17, CALCR, TAAR1 | S100A4 2471/4885CYP1A2 2184/4885BCL2 3739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.